Difference in immunological aspects of inflammation in idiopathic pulmonary fibrosis (IPF) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003
Radiological and morphological patterns in pneumoconiosis (PC) and exogenous toxic alveolitis (ETA) Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001
Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009
Chemical and hard metal induced exogenous toxic alveolitis (ETA) (follow up 1,5 years) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013
Diagnostic aspects of exogenous toxic alveolitis (ETA), due to polymetallic aerosols Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical problems Year: 2017
Biochemical markers of connective tissue damage at chronic toxic fibrosing alveolitis Source: Eur Respir J 2006; 28: Suppl. 50, 99s Year: 2006
Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Clara cell protein 16 (CC16) and markers of fibrosis in exogenous toxic (ETA) and exogenous allergic (EAA) alveolites Source: International Congress 2014 – Environment and mechanisms Year: 2014
The study of C5a complement component in patients with idiopathic pulmonary fibrosis, toxic fibrosing alveolitis and extrinsic allergic alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001
Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema Year: 2006
Indices of non-specific reactivity of the patient organism on subacute exogenous allergic alveolitis (EEA) Source: Eur Respir J 2002; 20: Suppl. 38, 160s Year: 2002
Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Clinical significance of different cytokines expression in lung tissue in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002
Statin-induced fibrotic nonspecific interstitial pneumonia Source: Eur Respir J 2002; 19: 577-580 Year: 2002
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Treprostinil effectively inhibits PDGF and TGF-ß1 induced extracellular matrix composition by IPF fibroblasts Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015